Analysts See $0.42 EPS for Exponent, Inc. (EXPO)

September 17, 2017 - By Marguerite Chambers

 Analysts See $0.42 EPS for Exponent, Inc. (EXPO)
Investors sentiment increased to 1.26 in 2016 Q4. Its up 0.20, from 1.06 in 2016Q3. It is positive, as 10 investors sold Exponent, Inc. shares while 51 reduced holdings. 23 funds opened positions while 54 raised stakes. 23.19 million shares or 1.53% less from 23.55 million shares in 2016Q3 were reported.
Copeland Capital Management Ltd Llc reported 244,623 shares. State Street holds 0% in Exponent, Inc. (NASDAQ:EXPO) or 573,433 shares. Blackrock reported 13,558 shares stake. Royal Bank & Trust Of Canada reported 21,870 shares or 0% of all its holdings. Aperio Gru Lc holds 0% or 9,048 shares. Price T Rowe Assocs Inc Md reported 1.19 million shares or 0.01% of all its holdings. Moreover, Riverbridge Lc has 0.69% invested in Exponent, Inc. (NASDAQ:EXPO) for 544,546 shares. North Carolina-based Savings Bank Of America De has invested 0% in Exponent, Inc. (NASDAQ:EXPO). Vanguard Group Incorporated has invested 0.01% in Exponent, Inc. (NASDAQ:EXPO). Pinebridge Invs Limited Partnership stated it has 0.01% in Exponent, Inc. (NASDAQ:EXPO). Miles Cap, a Iowa-based fund reported 3,757 shares. Huntington Retail Bank stated it has 6,602 shares or 0.01% of all its holdings. Conestoga Cap Advsr Limited Liability holds 2.35% or 585,282 shares. Metropolitan Life Ins Ny holds 0.01% in Exponent, Inc. (NASDAQ:EXPO) or 17,880 shares. Capstone Asset holds 6,056 shares.

Analysts expect Exponent, Inc. (NASDAQ:EXPO) to report $0.42 EPS on October, 18.They anticipate $0.00 EPS change or 0.00 % from last quarter’s $0.42 EPS. EXPO’s profit would be $10.81M giving it 42.08 P/E if the $0.42 EPS is correct. After having $0.51 EPS previously, Exponent, Inc.’s analysts see -17.65 % EPS growth. The stock increased 1.14% or $0.8 on September 15, reaching $70.7. About 245,729 shares traded or 157.35% up from the average. Exponent, Inc. (NASDAQ:EXPO) has risen 21.10% since September 17, 2016 and is uptrending. It has outperformed by 4.40% the S&P500.

Exponent, Inc. , along with its subsidiaries, is a science and engineering consulting company. The company has market cap of $1.82 billion. Exponent provides engineering and scientific consulting services to clients around the world. It has a 36.7 P/E ratio. The Company’s service offerings are provided on a project-by-project basis.

Another recent and important Exponent, Inc. (NASDAQ:EXPO) news was published by Nasdaq.com which published an article titled: “Exponent, Inc. (EXPO) Ex-Dividend Date Scheduled for August 30, 2017” on August 29, 2017.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.